Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Uterine Cervical Neoplasms 7Papillomavirus Infections 6Neoplasms 5Breast Neoplasms 4Uterine Cervical Dysplasia 3Melanoma 3Lung Neoplasms 3Herpes Zoster 3Condylomata Acuminata 3Vulvar Neoplasms 2Prostatic Neoplasms 2Influenza, Human 2Anus Neoplasms 2Wilms Tumor 1Whooping Cough 1Waldenstrom Macroglobulinemia 1Vaginal Neoplasms 1Tetanus 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Small Cell Lung Carcinoma 1Sarcoma 1Rheumatic Diseases 1Recurrence 1Psoriasis 1Persistent Infection 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms, Glandular and Epithelial 1Nasopharyngeal Neoplasms 1

Interventions

Carboplatin 341Paclitaxel 262Cisplatin 233Pemetrexed 226Docetaxel 206Erlotinib Hydrochloride 193Gemcitabine 178pembrolizumab 137Bevacizumab 121Radiotherapy 118Nivolumab 84Gefitinib 73Vinorelbine 64Cetuximab 58atezolizumab 47Afatinib 46durvalumab 44osimertinib 41Radiosurgery 35Ipilimumab 34Drug Therapy 32Taxes 30Albumin-Bound Paclitaxel 29130-nm albumin-bound paclitaxel 29Surgical Procedures, Operative 28Etoposide 25Irinotecan 24Sorafenib 21Cyclophosphamide 20Radiation 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Non-Small-Cell Lung × Vaccines × Clear all
NCT00654030 2018-04-09

Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer

University of Kentucky

Phase 2 Completed
12 enrolled 7 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡